Qinghai Publishes General Medical Consumables Platform
According to the Notice of General Medical Consumables Online Purchase in Qinghai Public Medical Institutions (Qinghai Pharmaceutical Acquisition [2018] 19) and Qinghai Pharmaceutical and Medical Consumption on November 22, 2008 The Notice of Material Centralized Purchasing Network issued by Qinghai Public Medical Institutions on General Medical Consumables Applying for Online Purchasing Requirements requires that "General Medical Consumables which have been included in the platform of pharmaceutical and medical consumables purchasing in our province, without purchasing records on the platform for six consecutive months, shall be selected and published by our center, and then a general medical consumables online purchasing catalogue shall be drawn up." On May 8, 2019, the first batch of products that have not been purchased by the platform for six consecutive months have been publicized and clarified, and now the product purchasing catalogue will be released for publication and platform transactions will be suspended.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Retatrutide/Tirzepatide/Cagri/Ghk-Cu 99% White Raw Power High Quality 2381089-83-2 Weight Loss Peptide
$178.7/G FOB
2026-07-06
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
-
Rare diseases pose a challenge to thepharmaceutical industry
-
Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
Recommend Reading
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
-
₹27,548 Crore Pharma Giant Cipla Enters Weight Management Battle as Obesity Demand Surges
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
BASF, Covestro, Huntsman Raise MDI Prices in North America Amid Global Supply Crunch
-
Premium Global Chemical Sourcing Requests (11–15 Aug 2025)
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
Luoyang Refining’s 2.78 Billion USD Ethylene Project Achieves Full Start-Up Annual Revenue to Hit 1.69 Billion USD
-
SKC Secures $40 Million IFC Investment for 70,000-Ton Biodegradable PBAT Plant in Vietnam Commercial Launch Set for 2026